Publications

Keep up with the latest research at the Faculty of Health.

The list below presents publications from the Faculty of Health, with the most recent at the top.

Sort by: Date | Author | Title

Askgaard, G., Jepsen, P., Jensen, M. D., Kann, A. E., Morling, J., Kraglund, F., Card, T., Crooks, C. & West, J. (2025). Response to Zhou et al. The American Journal of Gastroenterology, 120(5), 1157-1158. Article 10.14309/ajg.0000000000003305. https://doi.org/10.14309/ajg.0000000000003305
Aspelund, S. G., Halldorsdottir, T., Agustsson, G., Tobin, H. R. S., Wu, L. M., Amidi, A., Johannsdottir, K. R., Lutgendorf, S. K., Telles, R., Daly, H. F., Sigurdardottir, K., Figueiro, M. G., Redd, W. H., Valdimarsdottir, H. B. & Baldursdottir, B. (2025). The Effects of Light Therapy on Cognitive Function and Stress in Women With Breast Cancer Before Systemic Treatment. Cancer medicine, 14(22), Article e71412. https://doi.org/10.1002/cam4.71412
Assmann, S. L., Keszthelyi, D., Kimman, M. L., Breukink, S. O., Anastasiou, F., Assmann, R., Assmann, R. F. T. A., Bharucha, A., Bliss, D. Z., Brannigan, A. E., Chey, W. D., Chiarioni, G., Christensen, P., Conchillo, J. M., Croner, R. S., Desprez, C., Dibley, L., Dickman, R., Duelund-Jakobsen, J. ... Wexner, S. D. (2025). Faecal incontinence core outcome set: an international Delphi consensus exercise among patients, health-care professionals, and researchers. The Lancet Gastroenterology and Hepatology, 10(8), 769-778. https://doi.org/10.1016/S2468-1253(25)00013-5
Asuman, D., Ásgeirsdóttir, T. L. & Jarl, J. (2025). Anxious Dads and Depressed Moms: Child Disability and the Mental Health of Parents. Health Economics (United Kingdom), 34(7), 1326-1349. https://doi.org/10.1002/hec.4962
Asuman, D., Gerdtham, U. G., Alriksson-Schmidt, A. I., Nordin, M. & Jarl, J. (2025). The Impact of Child Disability on Parental Outcomes: Evidence From Sweden. Health Economics, 34(11), 2004-2036. https://doi.org/10.1002/hec.70017
Atalar, B., Mastroleo, F., Zaffaroni, M., Cremades, V., Doolan, P., Rønde, H. S., Clark, C. H., van der Heide, U. A., Boldrini, L., Eriksen, J. G., Forde, E., Kirby, A. M., Guckenberger, M., Garibaldi, C. & Jereczek-Fossa, B. A. (2025). Understanding national Societies’ needs and enhancing collaboration with ESTRO: A report of the national Societies survey 2024, on behalf of the ESTRO national Societies committee. Radiotherapy and Oncology, 210, Article 111006. https://doi.org/10.1016/j.radonc.2025.111006
Atanassova, D. V., Oosterman, J. M., Diaconescu, A. O., Mathys, C., Madariaga, V. I. & Brazil, I. A. (2025). Exploring when to exploit: the cognitive underpinnings of foraging-type decisions in relation to psychopathy. Translational Psychiatry, 15(1), Article 31. https://doi.org/10.1038/s41398-025-03245-2
Augustin, M., Bewley, A., Brüggen, M.-C., de Bruin-Weller, M. S., Ezzedine, K., Ferrucci, S. M., Gkalpakiotis, S., Herranz, P., Johansson, E. K., Kampe, T., Lapeere, H., Legat, F. J., Rehbinder, E. M., Szepietowski, J. C., Torres, T., Vestergaard, C., Werfel, T., Domenech, A., Massana, E. ... Gutermuth, J. (2025). European, multicentre, prospective observational phase IV clinical study to assess the impact of lebrikizumab on health-related well-being and control of skin manifestations in patients with moderate-to-severe atopic dermatitis (ADTrust): study protocol. BMJ Open, 15(7), e102155. Article e102155. https://doi.org/10.1136/bmjopen-2025-102155
Autier, P., Jørgensen, K. J. & Støvring, H. (2025). Answers to comments by Jonas Schmidt, Casper Urth Pedersen, and Sisse Helle Njor. Journal of Clinical Epidemiology, 177, Article 111588. https://doi.org/10.1016/j.jclinepi.2024.111588
Autio, M., Brück, O., Pollari, M., Karjalainen-Lindsberg, M.-L., Beiske, K., Jørgensen, J. M., Holte, H., Pellinen, T., Leivonen, S.-K. & Leppä, S. (2025). Characterization of tumor microenvironment and cell interaction patterns in testicular and diffuse large B-cell lymphomas. Haematologica, 110(6), 1339-1350. https://doi.org/10.3324/haematol.2024.286267
Avellaneda, N., Maroli, A., Pellino, G., Carvello, M., Tottrup, A., Bislenghi, G., Colpaert, J., D'Hoore, A., Giorgi, L., Juachon, P., Harsløf, S., Van Overstraeten, A. D. B., Olivera, P. A., Gomez, J., Holubar, S. D., Naranjo, E. L., Steele, S. R., Merchea, A., Shaker, A. ... Spinelli, A. (2025). Long-term comparative outcomes after ileocecal resection for inflammatory versus complicated Crohn's disease: A multicenter, retrospective study (Crohn's-Urg). Digestive and Liver Disease, 57(10), 1920-1926. https://doi.org/10.1016/j.dld.2025.07.009
Awad, A., Jonsson, M., Holgersson, J., Jakobsen, J. C., Hollenberg, J., Thomas, M., Garcia, P. D. W., Ringh, M., Grejs, A. M., Keeble, T. R., Bělohlávek, J., Cariou, A., Annoni, F., Lilja, G., Taccone, F. S., Rylander, C., Nielsen, N., Dankiewicz, J. & Nordberg, P. (2025). Intravascular vs. surface cooling in out-of-hospital cardiac arrest patients receiving hypothermia after hospital arrival: a post hoc analysis of the TTM2 trial. Intensive Care Medicine, 51(4), 721-730. https://doi.org/10.1007/s00134-025-07883-4
Aymerich, N., Bucheli, O. T. M., Portmann, K., Schlotheuber, L. J., Sigvaldadóttir, I., Baudry, J. & Eyer, K. (2025). Non-conjugated TLR agonists increase the quantity of antibodies but not their quality in a murine immunization model. Vaccine, 62, Article 127518. https://doi.org/10.1016/j.vaccine.2025.127518
Baad-Hansen, T. & Freund, S. S. (2025). Assessing Functional Outcomes. In H. Özger, F. H. Sim, A. Puri & L. Eralp (Eds.), Diagnosis and Treatment of Soft Tissue Tumors: Changes, Challenges and Strategies (pp. 233-238). Springer. https://doi.org/10.1007/978-3-031-77061-6_23
Baastrup Soendergaard, M., Håkansson, K. E. J., Hansen, S., Bjerrum, A.-S., Schmid, J. M., Johansson, S. L., Rasmussen, L. M., Johnsen, C. R., Bonnesen, B., Vijdea, R., von Bülow, A., Krogh, N. S., Hilberg, O., Ulrik, C. S. & Porsbjerg, C. (2025). Tezepelumab in real-life practice: Characteristics of patients commenced and efficacy in a nationwide, Danish cohort of patients with severe asthma. The Journal of Allergy and Clinical Immunology: In Practice. Advance online publication. https://doi.org/10.1016/j.jaip.2025.09.001
Babaee, A., Wichmann, T. O., Rasmussen, M. M., Brink, O., Olsen, D. A., Borris, L. C., Lesbo, M., Rasmussen, R. W., Salomon, C., Handberg, A., Mellergaard, M. & Hviid, C. V. B. (2025). Extracellular Vesicle Glial Fibrillary Acidic Protein as a Circulating Biomarker of Traumatic Brain Injury Severity. Journal of Molecular Neuroscience, 75(2), Article 69. https://doi.org/10.1007/s12031-025-02360-5
Babiloni, C., Arakaki, X., Baez, S., Barry, R. J., Benussi, A., Blinowska, K., Bonanni, L., Borroni, B., Bayard, J. B., Bruno, G., Cacciotti, A., Carducci, F., Carino, J., Carpi, M., Conte, A., Cruzat, J., D'Antonio, F., Della Penna, S., Percio, C. D. ... Kamondi, A. (2025). Alpha rhythm and Alzheimer's disease: Has Hans Berger's dream come true? Clinical Neurophysiology, 172, 33-50. https://doi.org/10.1016/j.clinph.2025.02.256
Backman, E. A., Gardberg, M., Luntamo, L., Peurla, M., Vahlberg, T., Borghammer, P., Stefanova, N., Wenning, G. & Kaasinen, V. (2025). Nigral Neuroinflammation and Dopaminergic Neurons in Parkinson's Disease and Atypical Parkinsonisms. Annals of Neurology, 97(6), 1096-1109. https://doi.org/10.1002/ana.27202
Bäckman, J., Wallert, J., Halvorsen, M. W., Roelstraete, B., de Schipper, E., Strom, N. I., Eide, T. O., Höffler, K. D., Mattheisen, M., Hansen, B., Kvale, G., Hagen, K., Haavik, J., Mataix-Cols, D., Rück, C., Nordic OCD and Related Disorders Consortium (NORDiC) & Crowley, J. J. (2025). Association Between Polygenic Risk and Symptom Severity Change After Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, 198(5), Article e33026. https://doi.org/10.1002/ajmg.b.33026
Bader-Larsen, K., Nielsen, B. U., Henriksen, E., Bryrup, T., Leo-Hansen, C., Mathiesen, I. H. M., Faurholt-Jepsen, D., Qvist, T., Oturai, P., Langdahl, B., Jeppesen, M., Olsen, H. V., Pressler, T., Skov, M. & Olsen, M. F. (2025). Body mass, linear growth, and body composition before and after the introduction of elexacaftor/tezacaftor/ivacaftor among children and adults with cystic fibrosis. Clinical Nutrition, 54, 132-139. https://doi.org/10.1016/j.clnu.2025.09.008
Bae, S. H., Jang, W. I., Yu, J. I., Park, H. C., Moon, J. E., Haustermans, K., Scorsetti, M., Høyer, M. & Kim, M. S. (2025). Radiotherapy for Locally Advanced Pancreatic Cancer in the Modern Era: A Systematic Review and Meta-Analysis. Cancers, 17(18), Article 2959. https://doi.org/10.3390/cancers17182959
Baekdal, J. A., Janns, L. K., Hansen, E. S. H., Meteran, H., Bendstrup, E. & Ulrik, C. S. (2025). The prevalence of interstitial lung disease and bronchiectasis in rheumatoid arthritis: A systematic review and meta-analysis. Sarcoidosis Vasculitis and Diffuse Lung Diseases, 42(4), Article 17112. https://doi.org/10.36141/svdld.v42i4.17112
Bælum, V. (2025). The foundations of good diagnostic practice. In O. Fejerskov & B. Nyvad (Eds.), Dental Caries : The disease and its clinical management (4 ed., pp. 85-102). Wiley-Blackwell.
Baez, E., Gyldenløve, M., Ben Abdallah, H., Emmanuel, T., Sørensen, J. A., Thomsen, S. F., Zachariae, C., Egeberg, A., Skov, L., Iversen, L. & Johansen, C. (2025). Oral Roflumilast Suppresses Proinflammatory Cytokine Signaling and Reduces CD4+ T-Cell and Neutrophil Infiltration in Psoriasis. The Journal of Investigative Dermatology, 145(12), 3079-3088.e3. https://doi.org/10.1016/j.jid.2025.04.034
Bager, P. & Bager, L. (2025). Digital Health in IBD. In A. Sturm & L. White (Eds.), Inflammatory Bowel Disease Nursing Manual (2nd ed., pp. 551-561). Springer. https://doi.org/10.1007/978-3-031-87503-8_50
Bahlis, N. J., Zonder, J., Karlin, L., Plesner, T., Paris, L., Wrobel, T., Hungria, V., Besemer, B., Crusoe, E., Silkjaer, T., Perrot, A., Moreau, P., Wu, K. L., Delimpasi, S., Dimopoulos, M. A., Levin, M. D., Mangiacavalli, S., Nnane, I., Kim, Y. J. ... Facon, T. (2025). Subcutaneous daratumumab plus carfilzomib and dexamethasone (D-Kd) versus carfilzomib and dexamethasone (Kd) in patients with relapsed/refractory multiple myeloma who received previous daratumumab treatment: LYNX study. Leukemia and Lymphoma, 2685-2696. https://doi.org/10.1080/10428194.2025.2561117